FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel Lynch, president and CEO, will provide an update of corporate activities at the 30th Annual J.P. Morgan Healthcare Conference on Thursday, January 12th at 10:00 a.m. Pacific Standard Time. The presentation will be held in the California East Ballroom at the Westin St. Francis located in San Francisco, California.
